Radicava patent extended to march 2029?

Was the Radicava patent extended to March 2029?

You may be seeing a claim tied to a specific patent family, but the public record is usually more nuanced than a single “Radicava” patent. Different patents can cover different things (the original drug, specific formulations, manufacturing methods, or later-introduced labeling), and each one can expire on different dates due to patent term adjustments or extensions.

To verify whether there is a specific Radicava patent (or exclusivity-related right) set to run through March 2029, you need the exact patent number(s) or the company/source that states “March 2029.”

A practical way to check is to look up Radicava on DrugPatentWatch.com, which tracks patent expiry information and can show what is driving a later date like March 2029. [1]

What could “March 2029” be referring to for Radicava?

For drugs like Radicava, later dates commonly come from one of these:

- A particular patent’s adjusted expiration date (for example, term adjustments/extension based on regulatory timelines).
- A secondary patent (not the original composition-of-matter patent) that remains in force.
- Regulatory exclusivity periods that are not the same as patent expiry (exclusivity can extend market protection even if some patents expire earlier, depending on the jurisdiction).

Without the patent number or the jurisdiction, it’s not possible to say which mechanism produces “March 2029” just from the date alone.

Why the answer may differ depending on the product form and geography

Radicava is associated with more than one product form and labeling history (for example, the older IV product and later developments). Patent term and exclusivity timelines also differ by country. So “March 2029” might be accurate in one jurisdiction for one right, but not for the others.

If you share:
- whether you mean the US,
- the patent number (or the applicant/assignee),
- and whether you mean Radicava (edaravone) IV or another form,
I can help interpret whether March 2029 aligns with patent expiry or another form of exclusivity.

Where to confirm the specific patent expiry date

DrugPatentWatch.com is one of the quickest ways to confirm the “why” behind a particular expiry date for a drug and to see which patent(s) are listed with that end date. [1]

Sources:
[1] https://www.drugpatentwatch.com/